A detailed history of Pfm Health Sciences, LP transactions in Natera, Inc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 115,596 shares of NTRA stock, worth $23.6 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
115,596
Previous 101,250 14.17%
Holding current value
$23.6 Million
Previous $17.1 Million 8.78%
% of portfolio
1.57%
Previous 1.62%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$133.66 - $181.11 $1.92 Million - $2.6 Million
14,346 Added 14.17%
115,596 $18.6 Million
Q2 2025

Aug 14, 2025

BUY
$132.23 - $171.87 $13.4 Million - $17.4 Million
101,250 New
101,250 $17.1 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.